Zobrazeno 1 - 10
of 101
pro vyhledávání: '"ALESSIA BARI"'
Autor:
Stefano Sacchi, Raffaella Marcheselli, Alessia Bari, Gabriele Buda, Anna Lia Molinari, Luca Baldini, Daniele Vallisa, Marina Cesaretti, Pellegrino Musto, Sonia Ronconi, Giorgina Specchia, Franco Silvestris, Luciano Guardigni, Angela Ferrari, Annalisa Chiapella, Angelo Michele Carella, Armando Santoro, Francesco Di Raimondo, Luigi Marcheselli, Samantha Pozzi
Publikováno v:
Haematologica, Vol 101, Iss 5 (2016)
Externí odkaz:
https://doaj.org/article/bf330cf097e946cdb8f253bbcc23eaa9
Autor:
Tamar Tadmor, Alessia Bari, Stefano Sacchi, Luigi Marcheselli, Eliana Valentina Liardo, Irit Avivi, Noam Benyamini, Dina Attias, Samantha Pozzi, Maria Christina Cox, Luca Baldini, Maura Brugiatelli, Massimo Federico, Aaron Polliack
Publikováno v:
Haematologica, Vol 99, Iss 1 (2014)
In this study we assessed the prognostic significance of absolute monocyte count and selected the best cut-off value at diagnosis in a large cohort of patients with diffuse large B-cell lymphoma. Data were retrieved for therapy-naïve patients with d
Externí odkaz:
https://doaj.org/article/1d318177f13e4479ac8436fd14aaec54
Autor:
Alessia Bari, Luigi Marcheselli, Raffaella Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Sacchi
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 3, Iss 1, Pp e2011065-e2011065 (2011)
Background: Relatively little information on secondary cancers is available for Non-Hodgkin lymphoma (NHL) treated patients as treatments have been less effective compared to those for Hodgkin Lymphoma. Recently, evolving chemotherapy (CHT) in combin
Externí odkaz:
https://doaj.org/article/582129497c214c86abfe56fe2e73a1a1
Autor:
Raffaella Marcheselli, Eliana Valentina Liardo, Luigi Marcheselli, Alessia Bari, Samantha Pozzi, Stefano Sacchi
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 3, Iss 1, Pp e2011065-e2011065 (2011)
Background: Relatively little information on secondary cancers is available for Non-Hodgkin lymphoma (NHL) treated patients as treatments have been less effective compared to those for Hodgkin Lymphoma. Recently, evolving chemotherapy (CHT) in combin
Externí odkaz:
https://doaj.org/article/a87de0b063894e86ac33a370de6b93c1
Autor:
Stefano Sacchi, Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Samantha Pozzi, Paolo G. Gobbi, Francesco Angrilli, Maura Brugiatelli, Pellegrino Musto, Massimo Federico
Publikováno v:
Haematologica, Vol 93, Iss 9 (2008)
Background Improved treatment has increased the life expectancy of patients with non-Hodgkin’s lymphoma, but few studies have addressed the issue of second cancer in patients treated for diffuse large B-cell lymphoma. The aims of this study were to
Externí odkaz:
https://doaj.org/article/18a392b22f23485f98c226df781e7a9a
Autor:
Stefano Sacchi, Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Samantha Pozzi, Stefano Luminari, Marco Lombardo, Gabriele Buda, Antonio Lazzaro, Paolo G. Gobbi, Caterina Stelitano, Fortunato Morabito, Giovanni Quarta, Maura Brugiatelli
Publikováno v:
Haematologica, Vol 93, Iss 3 (2008)
Background Relatively little information is available on the incidence of secondary cancer in non-Hodgkin’s lymphoma. The aim of this long-term follow-up study was to determine the incidence, the time free of second tumors, and risk factors for dev
Externí odkaz:
https://doaj.org/article/deac9396fda34d4ab129ce1c706ef825
Autor:
Maria E. Nizzoli, Martina Manni, Chiara Ghiggi, Alessandro Pulsoni, Gerardo Musuraca, Michele Merli, Catello Califano, Alessia Bari, Massimo Massaia, Annarita Conconi, Pellegrino Musto, Donato Mannina, Tommasina Perrone, Francesca Re, Sara Galimberti, Guido Gini, Monia Capponi, Umberto Vitolo, Sara V. Usai, Piero M. Stefani, Filippo Ballerini, Anna M. Liberati, Elsa Pennese, Domenico Pastore, Tetiana Skrypets, Hillary Catellani, Luigi Marcheselli, Massimo Federico, Stefano Luminari
Publikováno v:
Hematological Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1ebc4e3a81775fd7c4ecb6c1e678ecf
https://doi.org/10.1002/hon.3184
https://doi.org/10.1002/hon.3184
Autor:
Fabio Gelsomino, Samantha Pozzi, Alessia Bari, Francesco Caputo, Massimo Dominici, Krisida Cerma, Martina Fanelli
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:766-770
Introduction Pazopanib, a tyrosine kinase inhibitor (TKI), is a standard treatment for various tumours, including metastatic non-adipocytic soft-tissue sarcomas. In literature, erythrocytosis has been described as a TKI-related condition. Case report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33f7d9b9df2708c1873ee11bcfb8154
https://doi.org/10.1177/1078155220950440
https://doi.org/10.1177/1078155220950440
Autor:
Lydia Scarfò, Silvia Ferrari, Anna Maria Frustaci, Monica Tani, Alessia Bari, Eloise Scarano, Maria Colia, Pamela Ranghetti, Piera Angelillo, Paola Ronchi, Maurilio Ponzoni, Andrés J. M. Ferreri, Paolo Ghia
Publikováno v:
Blood advances. 6(18)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce74b25e59816484dd24ce54c7d961cf
https://pubmed.ncbi.nlm.nih.gov/35613463
https://pubmed.ncbi.nlm.nih.gov/35613463
Autor:
Luca Nassi, Vitaliana De Sanctis, Giacomo Loseto, Chiara Gerardi, Eleonora Allocati, Sabino Ciavarella, Carla Minoia, Attilio Guarini, Alessia Bari
Publikováno v:
Cancers, Vol 14, Iss 519, p 519 (2022)
Background: The increase of lymphoma patient survival led to a modification of the incidence of long-term sequelae, including second malignancies (SM). Several groups have dealt with the incidence of SM, according to the primary treatment; however, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7a92dae2c07e350e91863824e39ae2
https://hdl.handle.net/11380/1264808
https://hdl.handle.net/11380/1264808
